PPCB Propanc Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Eyl 25, 2026
$0,51
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,0952 haftanın en düşüğü
$6,7952 haftanın en yükseği
Piyasa Değeri (MRQ)
$2M
P/E
-0.0
Hisse Başına Kâr
$-17.62
rozetleriniz
52 Haftlık Aralık
$0–$7
Analist Derecelendirmesi
·
Fiyat Hedefi
·
P/E
-0.0
ROE
-190.0%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PPCB Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.51
Piyasa Değeri (MRQ)
$2M
P/E
-0.0
Hisse Başına Kâr
$-17.62
ROE
-190.0%
52 Haftlık Aralık
$0–$7
PPCB Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 18 Mayıs 2026 | 1-for-25 | Ters |
| 29 Ocak 2025 | 1-for-2 | Ters |
| 19 Kasım 2020 | 1-for-1000 | Ters |
| 24 Haziran 2019 | 1-for-500 | Ters |
| 20 Nisan 2017 | 1-for-250 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-17.622022-06-30 → 2026-06-30
Serbest Nakit Akışı$-6M2019-06-30 → 2026-06-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PPCB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.05Y ort. ≈-0.1 | ≈-0.1 | · | · | |
| F/D (MRQ) | 0.25Y ort. ≈-107.2 | ≈-107.2 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.3 | · | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.35Y ort. ≈-251.6 | ≈-251.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.2 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PPCB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -116.4%5Y ort. ≈-2563.4% | ≈-2563.4% | · | · | |
| ROE | -190.0%5Y ort. ≈-234.7% | ≈-234.7% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PPCB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 2.55Y ort. ≈0.8 | ≈0.8 | · | · | |
| Quick Ratio (Cari Oran) | 0.25Y ort. ≈0.1 | ≈0.1 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | $28.1K | $30.5K | $29.0K | · | · | |
| R&D Expense | $625.5K | $223.7K | $248.1K | $247.9K | $256.1K | $231.0K | $180.0K | $260.3K | $2M | $971.8K | $1M | $134.3K | |
| SG&A Expense | $670.6K | $109.0K | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $5M | $5M | $2M | |
| Operating Expenses | $18M | $57M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $6M | $7M | $2M | |
| Operating Income | $-18M | $-57M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-6M | $-7M | $-2M | |
| Interest Expense | · | · | · | $532.8K | $568.8K | $449.5K | $2M | $1M | $3M | $3M | $4M | $1M | |
| Interest Income | · | · | · | · | $5.6K | $1 | $946 | $31 | $87 | $685 | $2.0K | $33 | |
| Other Non-op | $-6.0K | · | $-413.6K | $-1M | $-722.2K | $-327.2K | $-1M | $-3M | $-3M | $-2M | $-3M | $-2M | |
| Pretax Income | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | · | · | · | |
| Income Tax | · | · | $-129.1K | $-129.8K | $-55.0K | $-113.4K | $-134.7K | $-115.4K | $-179.3K | $-305.7K | $-72.5K | $-77.5K | |
| Net Income | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | $-9M | $-3M | |
| EPS (Basic) | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 | $-0.80 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,123,709 | 158,727 | 1,417 | 1,738,802 | 68,219 | 3,032,612 | · | · | · | · | · | · | |
| Shares (Diluted) | 1,123,709 | 158,727 | 1,417 | 1,738,802 | 68,219 | · | · | · | · | · | · | · | |
| EBITDA | $-18M | $-57M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-6M | $-7M | $-2M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832.0K | $12.1K | $21.1K | $10.0K | $4.1K | $2.3K | $67.0K | $2.4K | $19.9K | $69.0K | $121.1K | $107.6K | |
| Prepaid Expense | $8M | $8M | · | $6.1K | $8.6K | · | · | $83.3K | $34.7K | $4.8K | $210.1K | $502.6K | |
| Other Current Assets | $34.9K | $1.4K | $1.4K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $9M | $8M | $25.4K | $19.0K | $15.0K | $6.6K | $69.0K | $91.1K | $60.9K | $82.0K | $362.8K | $621.9K | |
| PP&E (Net) | $3.9K | · | · | $302 | $2.0K | $4.3K | $5.7K | $8.4K | $8.3K | $10.8K | $12.5K | $3.5K | |
| PP&E (Gross) | $31.3K | $25.1K | $25.5K | $25.4K | $28.6K | $28.6K | $26.3K | $26.7K | $25.2K | $26.2K | $25.3K | $15.7K | |
| Accum. Depreciation | $27.4K | $25.1K | $25.5K | $25.1K | $26.6K | $24.4K | $20.6K | $18.3K | $17.0K | $15.4K | $12.7K | $12.2K | |
| Total Assets | $13M | $20M | $72.4K | $60.3K | $81.7K | $13.1K | $98.5K | $101.7K | $71.4K | $95.1K | $379.1K | $627.1K | |
| Accounts Payable | $1M | $1M | $1M | $966.7K | $943.0K | $1M | $842.2K | $917.3K | $1M | $483.5K | $370.1K | $236.5K | |
| Short-term Debt | · | $543.3K | $204.7K | · | · | · | · | · | · | · | $2.2K | $27.6K | |
| Current Liabilities | $3M | $6M | $4M | $3M | $3M | $3M | $4M | $4M | $7M | $6M | $3M | $4M | |
| Capital Leases | $23.8K | $41.7K | · | · | $42.3K | · | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $58.0K | $109.6K | |
| Total Liabilities | $3M | $6M | $4M | $3M | $3M | $3M | $4M | $4M | · | · | · | · | |
| Long-term Debt | · | $537.9K | $399.3K | $390.5K | $926.4K | $624.6K | $2M | $2M | $5M | $3M | $1M | · | |
| Total Debt | · | $543.3K | $204.7K | · | · | · | · | · | · | · | $2.2K | $27.6K | |
| Common Stock | $3.3K | $464 | $8 | $6.0K | $220 | $14.1K | $258 | $968 | $93 | $4.6K | $2.9K | $347.4K | |
| Paid-in Capital | $153M | $138M | $62M | $60M | $57M | $54M | $51M | $46M | $38M | $33M | $28M | $17M | |
| Retained Earnings | $-144M | $-126M | $-67M | $-65M | $-62M | $-58M | $-56M | $-51M | $-45M | $-38M | $-30M | $-21M | |
| Treasury Stock | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | · | · | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $357.9K | $-141.7K | $131.3K | $101.0K | |
| Stockholders' Equity | $9M | $14M | $-4M | $-3M | $-3M | $-3M | $-4M | $-4M | $-7M | $-5M | $-3M | $-3M | |
| Liabilities + Equity | $13M | $20M | $72.4K | $60.3K | $81.7K | $13.1K | $98.5K | $101.7K | $71.4K | $95.1K | $379.1K | $627.1K | |
| Shares Outstanding | 3,310,827 | 464,471 | 7,980 | 6,031,250 | 220,351 | 14,055,393 | 258,120 | 967,993 | 92,810 | 4,553,806 | 2,914,465 | 347,442,013 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $5M | · | $2.4K | $72.5K | $82.9K | $300.4K | · | $516.1K | $2M | $2M | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Operating Cash Flow | $-6M | $-405.2K | $-935.1K | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-5M | $-1M | |
| CapEx | $4.9K | · | · | · | · | · | · | $2.9K | · | · | $9.9K | $3.9K | |
| Investing Cash Flow | $-4.9K | · | · | · | · | · | · | $-2.9K | · | · | · | $-5.6K | |
| Stock Issued | $3M | · | $23.1K | $24.7K | $99.3K | · | $450.0K | $1M | · | · | $0 | $29.0K | |
| Net Stock Activity | $3M | · | $23.1K | $24.7K | $99.3K | · | $450.0K | $1M | · | · | $0 | $29.0K | |
| Financing Cash Flow | $6M | $490.8K | $941.9K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | · | · | |
| Net Change in Cash | $819.9K | $-9.0K | $11.0K | $6.0K | $1.8K | $-64.8K | $64.6K | $-17.5K | $-49.1K | · | · | · | |
| Free Cash Flow | $-6M | · | · | · | · | · | · | $-2M | · | · | $-5M | $-1M | |
| Levered FCF | · | · | · | · | · | · | · | $-3M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -116.4% | -598.1% | -2744.0% | -3747.8% | -5610.6% | -4332.1% | -4736.7% | -6655.6% | -8457.7% | -3318.1% | -1870.5% | -921.4% | |
| ROE | -190.0% | -1209.0% | 48.7% | 87.8% | 89.0% | 79.6% | 111.7% | 149.3% | 104.1% | 196.5% | 335.0% | 153.0% | |
| ROIC | · | · | 40.1% | 54.3% | 64.5% | 55.9% | · | 59.6% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | |
| Quick Ratio | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | 0.0 | -0.1 | · | · | · | · | · | · | · | -0.0 | -0.0 | |
| Interest Coverage | · | · | · | -3.3 | -3.5 | -4.0 | -2.0 | -2.0 | -1.4 | -1.8 | -1.5 | -1.3 |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.84 | $1.20 | $-0.01 | $-0.52 | $-0.01 | $-0.22 | $-0.01 | $-4.44 | $-0.15 | $-1.19 | $-0.00 | $-0.01 | |
| Cash Flow / Share | $-5.06 | $-0.10 | $-0.01 | $-0.64 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.25 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | |
| EPS (TTM) | $-17.62 | $-14.85 | $-1420.53 | $-1.80 | $-49.23 | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | $-9M | $-3M | |
| Market Cap | $5M | $48M | $1M | $2M | $1.63B | $1.45B | $2.01T | $11.62T | $2552.27T | · | · | · | |
| Enterprise Value | · | $49M | $1M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.1 | -0.3 | 0.0 | -0.1 | -0.2 | · | · | · | · | · | · | · | |
| P/B | 0.5 | 3.5 | -0.3 | -0.5 | -539.3 | -473.8 | -552898.5 | -2700599.5 | -378006844.7 | · | · | · | |
| P / Tangible Book | 0.5 | 3.5 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.9 | -118.9 | -1.3 | -1.5 | -1135.3 | -1269.0 | -1088533.0 | -5638692.9 | -1172033079.3 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | -5630837.2 | · | · | · | · | |
| EV / EBITDA | · | -0.9 | -0.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1174.7% | -357.8% | -54635769.2% | -666.7% | -665.3% | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $375.7K | $169.7K | $20.0K | $60.2K | $53.5K | $54.1K | $54.4K | $61.7K | $52.4K | $65.4K | $114.0K | $16.2K | $5.7K | $66.0K | $74.9K | $101.3K | |
| SG&A Expense | $-14M | $6M | $4M | $5M | $-53M | $53M | $153.6K | $220.8K | $192.9K | $348.8K | $318.2K | $393.8K | $197.3K | $311.8K | $525.6K | $465.1K | |
| Operating Expenses | $3M | $6M | $4M | $5M | $4M | $53M | $213.4K | $290.8K | $259.9K | $420.9K | $438.1K | $417.2K | $209.6K | $386.2K | $608.0K | $572.8K | |
| Operating Income | $-3M | $-6M | $-4M | $-5M | $-4M | $-53M | $-213.4K | $-290.8K | $-259.9K | $-420.9K | $-438.1K | $-417.2K | $-209.6K | $-386.2K | $-608.0K | $-572.8K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $133.1K | $264.5K | $178.2K | · | $157.2K | $98.6K | $162.8K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2 | |
| Other Non-op | $-448.2K | $43.0K | $563.3K | $-164.2K | $-426.2K | · | $-216.8K | $-63.5K | $-98.9K | $-106.1K | $-274.9K | $66.4K | $-537.2K | $-425.3K | $-6.7K | $-44.5K | |
| Pretax Income | $-5M | $-6M | $-3M | $-5M | $-4M | $-54M | $-430.2K | $-354.3K | $-358.8K | $-527.0K | $-713.0K | $-350.9K | $-746.8K | $-811.5K | $-614.7K | $-617.3K | |
| Income Tax | · | · | · | · | · | · | · | · | $-237 | $-275 | $-128.6K | · | $1.2K | $-1.7K | $-129.3K | · | |
| Net Income | $-5M | $-6M | $-3M | $-5M | $-4M | $-54M | $-430.2K | $-354.3K | $-358.6K | $-526.7K | $-584.4K | $-350.9K | $-748.0K | $-809.8K | $-485.4K | $-617.3K | |
| EPS (Basic) | $-16.65 | $-0.28 | $-0.30 | $-0.39 | $-290.52 | $-12.50 | $-32.23 | $-35.97 | $684.85 | $-545.79 | $-1559.55 | $-0.04 | $1.28 | $-0.42 | $-0.53 | $-2.13 | |
| EPS (Diluted) | $-16.65 | $-0.28 | $-0.30 | $-0.39 | $-290.52 | $-12.50 | $-32.23 | $-35.97 | $684.85 | $-545.79 | $-1559.55 | $-0.04 | $1.28 | $-0.42 | $-0.53 | $-2.13 | |
| Shares (Basic) | · | 22,427,486 | 13,360,358 | 12,331,526 | · | 4,325,994 | 13,347 | 9,849 | · | 994 | 397 | 10,989,681 | · | 1,924,074 | 960,471 | 473,589 | |
| Shares (Diluted) | · | 22,427,486 | 13,360,358 | 12,331,526 | · | 4,325,994 | 13,347 | 9,849 | · | 994 | 397 | 10,989,681 | · | 1,924,074 | 960,471 | 473,589 | |
| EBITDA | · | $-6M | $-4M | $-5M | · | $-53M | $-213.4K | $-290.8K | · | $-420.9K | $-438.1K | $-417.2K | · | $-386.2K | $-608.0K | $-572.8K |
Bilanço
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832.0K | $443.7K | $561.2K | $602.7K | $12.1K | $50.8K | $14.6K | $9.3K | $21.1K | $6.2K | $71.7K | $6.6K | $10.0K | $93.2K | $24.5K | $19.4K | |
| Prepaid Expense | $8M | $8M | $7M | $8M | $8M | $10M | $1.4K | $9.0K | · | $1.4K | $12.1K | $20.4K | $6.1K | · | $25.2K | $15.8K | |
| Other Current Assets | $34.9K | $35.1K | $1.4K | $8.8K | $1.4K | $1.3K | · | · | $1.4K | · | · | · | · | · | · | · | |
| Current Assets | $9M | $8M | $8M | $9M | $8M | $10M | $18.0K | $21.5K | $25.4K | $12.9K | $210.8K | $145.8K | $19.0K | $96.6K | $54.2K | $37.9K | |
| PP&E (Net) | $3.9K | $4.2K | $4.4K | $2.4K | · | · | · | · | · | · | $50 | $160 | $302 | $634 | $1.1K | $1.4K | |
| PP&E (Gross) | $31.3K | $31.2K | $30.2K | $27.8K | $25.1K | $23.8K | $23.6K | $26.5K | $25.5K | $24.9K | $26.0K | $24.5K | $25.4K | $25.6K | $26.0K | $28.6K | |
| Accum. Depreciation | $27.4K | $27.0K | $25.8K | $25.4K | $25.1K | $23.8K | $23.6K | $26.5K | $25.5K | $24.9K | $26.0K | $24.4K | $25.1K | $24.9K | $24.9K | $27.2K | |
| Total Assets | $13M | $14M | $15M | $18M | $20M | $23M | $78.5K | $63.6K | $72.4K | $37.3K | $241.9K | $180.4K | $60.3K | $143.7K | $108.0K | $94.3K | |
| Accounts Payable | $1M | $973.7K | $957.5K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $966.7K | $918.2K | $914.5K | $899.2K | |
| Short-term Debt | · | · | · | · | $543.3K | $281.5K | $168.2K | $213.1K | $204.7K | $132.0K | $132.0K | $126.0K | · | · | $72.4K | · | |
| Current Liabilities | $3M | $3M | $4M | $4M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Capital Leases | $23.8K | $30.3K | $35.2K | $42.1K | $41.7K | · | · | · | · | · | · | · | · | $24.9K | $30.9K | $39.4K | |
| Total Liabilities | $3M | $4M | $4M | $4M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Long-term Debt | · | $55.0K | $55.0K | $107.0K | $537.9K | $438.6K | $409.8K | $381.8K | $399.3K | $583.0K | $687.6K | $397.4K | $390.5K | $519.7K | · | $913.6K | |
| Total Debt | · | · | · | · | · | $281.5K | $168.2K | $213.1K | · | $132.0K | $132.0K | $126.0K | · | · | $72.4K | · | |
| Common Stock | $3.3K | $21.9K | $13.4K | $12.8K | $464 | $11.6K | $14 | $688.0K | $8 | $109.7K | $36.2K | $14.8K | $6.0K | $3M | $1M | $677.2K | |
| Paid-in Capital | $153M | $149M | $144M | $144M | $138M | $138M | $62M | $61M | $62M | $61M | $61M | $61M | $60M | $57M | $58M | $58M | |
| Retained Earnings | $-144M | $-141M | $-134M | $-130M | $-126M | $-122M | $-67M | $-67M | $-67M | $-66M | $-66M | $-65M | $-65M | $-64M | $-63M | $-63M | |
| Treasury Stock | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $9M | $10M | $10M | $14M | $14M | $18M | $-4M | $-4M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Liabilities + Equity | $13M | $14M | $15M | $18M | $20M | $23M | $78.5K | $63.6K | $72.4K | $37.3K | $241.9K | $180.4K | $60.3K | $143.7K | $108.0K | $94.3K | |
| Shares Outstanding | 3,310,827 | 21,859,281 | 13,449,688 | 12,806,748 | 464,471 | 11,611,782 | 14,508 | 688,022,017 | 7,980 | 109,706,411 | 36,169,023 | 14,833,210 | 6,031,250 | 2,621,297,786 | 1,245,699,501 | 677,177,717 |
Nakit Akışı
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $3M | $3M | · | · | · | · | · | · | · | $0 | $0 | $0 | $2.4K | |
| Operating Cash Flow | $-2M | $-1M | $-999.1K | $-2M | $-92.2K | $-136.2K | $18.7K | $-235.5K | $-260.0K | $-102.8K | $-238.9K | $-333.5K | $-178.0K | $-192.7K | $-225.2K | $-509.3K | |
| CapEx | $21 | $154 | $2.3K | $2.5K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $-21 | $-154 | $-2.3K | $-2.5K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $3M | · | · | · | · | $12.0K | · | · | · | $0 | $0 | $0 | $24.7K | |
| Net Stock Activity | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | · | $24.7K | |
| Financing Cash Flow | $2M | $981.6K | $965.1K | $3M | $72.8K | $187.5K | $54.8K | $215.7K | $251.0K | $66.6K | $273.9K | $350.3K | $100.0K | $269.5K | $250.0K | $494.2K | |
| Net Change in Cash | $388.3K | $-117.5K | $-41.5K | $590.6K | $-38.7K | $36.1K | $5.4K | $-11.8K | $14.9K | $-65.4K | $65.0K | $-3.4K | $-83.2K | $68.8K | $5.1K | $15.3K | |
| Free Cash Flow | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -34.5% | -40.7% | -53.6% | · | -479.2% | -268.5% | -290.4% | · | -581.7% | -334.0% | -255.5% | · | -517.1% | -444.9% | -789.3% | |
| ROE | · | -45.6% | -98.2% | -94.4% | · | -751.3% | 11.1% | 10.0% | · | 15.9% | 18.0% | 12.2% | · | 27.5% | 16.6% | 24.3% | |
| ROIC | · | · | · | · | · | · | · | · | · | 11.8% | 10.5% | · | · | 13.1% | 16.9% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.4 | 2.1 | 2.5 | · | 2.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Quick Ratio | · | 0.1 | 0.2 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | · | · | · | · | 0.0 | -0.0 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | · | -0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.2 | -1.7 | -2.3 | · | -2.5 | -6.2 | -3.5 |
Hisse Başına
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.45 | $0.78 | $1.12 | · | $1.56 | $-286.65 | $-0.01 | · | $-0.03 | $-0.10 | $-0.20 | · | $-0.00 | $-0.00 | $-0.00 | |
| Cash Flow / Share | · | · | · | $-0.16 | · | · | · | $-0.00 | · | · | · | $-0.03 | · | · | · | · | |
| Cash / Share | · | $0.02 | $0.04 | $0.05 | · | $0.00 | $1.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | · | $-291.49 | $-303.71 | $-335.64 | · | $604.15 | $70.86 | $-1456.46 | · | $-2104.10 | $-1558.73 | $0.29 | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-18M | $-66M | $-63M | · | $-55M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-2M | $-3M | |
| Market Cap | · | $2M | $7M | $22M | · | $64M | $6 | $412.8K | · | $702.1K | $868.1K | $723.9K | · | $2.62B | $1.49B | $1.63B | |
| Enterprise Value | · | · | · | · | · | $64M | $153.6K | $616.7K | · | $827.9K | $928.4K | $843.2K | · | · | $1.49B | · | |
| P/E | · | -0.0 | -0.0 | -0.0 | · | 0.0 | 0.0 | 0.0 | · | -0.0 | -0.0 | 10.8 | · | · | · | · | |
| P/B | · | 0.2 | 0.7 | 1.5 | · | 3.5 | 0.0 | -0.1 | · | -0.2 | -0.2 | -0.2 | · | -891.2 | -512.7 | -587.2 | |
| P / Tangible Book | · | 0.2 | 0.7 | 1.5 | · | 3.5 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | -11.2 | · | · | · | -1.8 | · | · | · | -2.2 | · | · | · | -3191.0 | |
| Earnings Yield | · | -274990.6% | -56599.0% | -19743.5% | · | 10984.5% | 276796.9% | -3792864.6% | · | -513696.3% | -101479.8% | 9.3% | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Net Gelir | $-19M | $-59M | $-2M | $-3M | $-3M |
| Seyreltilmiş Hisse Başı Kâr | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | 0.0 | -0.1 | · | · |
| Cari Oran | 2.5 | 1.5 | 0.0 | 0.0 | 0.0 |
| Cari Oran | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-6M | · | · | · | · |
Kurumsal Sahipler (13F)
Kurumsal faaliyet — Q1 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 4 (+1 önceki Ç'ye göre) | 3 (+2 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | +334K |
Q4 2025 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Putney Consultants Ltd. | 02 Ocak 2015 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 3 içeriden öğrenenler · 2 yöneticiler · 3 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| James Andrew Nathanielsz | CEO/CFO | 17 Ağustos 2021 A | 2.800.000 | 0 | 0 | $0 |
| Julian Norman Kenyon | Chief Scientific Officer | 17 Ağustos 2021 A | 3.420.005 | 0 | 0 | $0 |
| Josef Zelinger | Yönetim kurulu üyesi | 05 Temmuz 2023 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PPCB | $5M | -0.1 | · | · | -190.0% | · |
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-K dosyalandı Eyl 25, 2026